 Role thromboxane serotonin mediators development spontaneous alterations coronary blood flow neointimal proliferation canine models chronic coronary artery stenoses endothelial injury Platelet-mediated obstruction stenotic endothelium-injured coronary arteries important abrupt progression chronic stable unstable coronary heart disease syndromes patients Transcardiac accumulation thromboxane serotonin patients chronic stable angina unstable angina study anesthetized open dogs coronary artery stenosis endothelial injury thromboxane serotonin important mediators intermittent coronary obstruction platelet aggregation dynamic vasoconstriction Furthermore thromboxane synthesis inhibitors receptor antagonists serotonin receptor antagonists substantial protection repetitive platelet aggregation dislodgment canine models coronary artery stenosis endothelial injury systemic catecholamine concentrations observations unsedated dogs coronary artery stenosis endothelial injury recurrent platelet attachment dislodgment cause cyclic flow alterations thromboxane synthesis inhibitors receptor antagonists serotonin receptor antagonists instrumented dogs coronary stenosis endothelial injury recurrent platelet attachment dislodgment neointimal proliferation severity days weeks morphologic appearance neointimal proliferation identical patients restenosis coronary angioplasty